Blood Cancer Clinical Trials

17 recruiting

Blood Cancer Trials at a Glance

20 actively recruiting trials for blood cancer are listed on ClinicalTrialsFinder across 6 cities in 9 countries. The largest study group is Not Applicable with 7 trials, with the heaviest enrollment activity in New York, Boston, and Middletown. Lead sponsors running blood cancer studies include Memorial Sloan Kettering Cancer Center, Blood Cancer United, and Australasian Leukaemia and Lymphoma Group.

Browse blood cancer trials by phase

Treatments under study

About Blood Cancer Clinical Trials

Looking for clinical trials for Blood Cancer? There are currently 17 studies actively recruiting participants. Clinical trials offer access to new treatments before they are widely available, and every approved therapy in use today was first tested through a clinical trial.

Below you can browse trials, sign up for alerts when new Blood Cancer trials open, and view eligibility criteria for each study. Each listing includes the study phase, locations, and enrollment details.

Frequently Asked Questions

Common questions about Blood Cancer clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 120 of 20 trials

Recruiting
Phase 1

Autologous T Cells Transduced With Retroviral Vectors Expressing TCRs for Participant-specific Neoantigens in Patients With Hematologic Malignancies

Leukemia, Lymphocytic, AcuteBlood CancerMyeloid Leukemia, Acute+8 more
National Cancer Institute (NCI)86 enrolled1 locationNCT06904066
Recruiting
Not Applicable

Defining the Role of Palliative carE for Patients With Hematologic Malignancies Undergoing Adoptive CEllular Therapy

Multiple MyelomaLymphomaLeukemia+2 more
Massachusetts General Hospital90 enrolled1 locationNCT05646576
Recruiting
Phase 2

Pharmacogenomics for Better Treatment of Fungal Infections Clinical Trial

Haematological MalignancyBlood CancerFungal Infection+1 more
The University of Queensland104 enrolled7 locationsNCT06510699
Recruiting
Phase 2

Open-Label, Phase II Trial of Isatuximab for Patients With Refractory Immune Cytopenias After Allogeneic Hematopoietic Cell Transplantation

Blood CancerRefractory Immune Cytopenias
Memorial Sloan Kettering Cancer Center12 enrolled7 locationsNCT05873205
Recruiting
Phase 1Phase 2

A Multi-Site Break Through Cancer Trial: Targeting Measurable Residual Disease in Patients With Acute Myeloid Leukemia: A Phase 1/2 Study of Tagraxofusp, Azacitidine, and Venetoclax

LeukemiaBlood CancersBlood Cancer+1 more
Jacqueline Garcia, MD31 enrolled2 locationsNCT07148180
Recruiting
Not Applicable

DISCOVERY: Evaluating a Decision Support Tool for Adults Seen in Hematology/Oncology Clinics

Multiple MyelomaLymphomaLeukemia+2 more
UNC Lineberger Comprehensive Cancer Center500 enrolled1 locationNCT06296368
Recruiting

Development of a Multi-biomarker Panel for Prognostic Stratification and Treatment Response Prediction in Acute Graft Versus Host Disease of the Gut

Blood Cancer
IRCCS Azienda Ospedaliero-Universitaria di Bologna90 enrolled1 locationNCT07305090
Recruiting

Immune Profiling for Cancer Immunotherapy Response

CancerHematologic MalignancyTumor, Solid+1 more
Dartmouth-Hitchcock Medical Center1,500 enrolled1 locationNCT06116032
Recruiting
Not Applicable

Effect of APA on Sleep Quality in Children With Cancer From 5 to 16 Years

SleepChild, OnlyBlood Cancer+1 more
University Hospital, Clermont-Ferrand30 enrolled1 locationNCT06455592
Recruiting
Not Applicable

A Music Therapy Study for Blood Cancer Survivors With Cognitive Difficulties

LymphomaLeukemiaMyeloma+1 more
Memorial Sloan Kettering Cancer Center60 enrolled7 locationsNCT07052916
Recruiting
Phase 2

Take the Reins: The Effects of Nutrient Timing on Cancer-related Fatigue

SurvivorshipNeoplasmsFatigue+3 more
University of Maryland, Baltimore96 enrolled1 locationNCT06482515
Recruiting
Not Applicable

Lifestyle Intervention for Veterans With Blood Cancer: Tele-Intervention

Blood Cancers
VA Pittsburgh Healthcare System30 enrolled1 locationNCT07058571
Recruiting
Phase 1Phase 2

IDP-023 as a Single Agent and in Combination With Antibody Therapies in Patients With Advanced Hematologic Cancers

Multiple MyelomaNHLRefractory Non-Hodgkin Lymphoma+1 more
Indapta Therapeutics, INC.128 enrolled12 locationsNCT06119685
Recruiting
Not Applicable

Driving Inclusivity, Validity, and Equity in Research Through Strategic Engagement (DIVERSE)

LeukemiaBlood Cancer
Dana-Farber Cancer Institute40 enrolled1 locationNCT06469307
Recruiting

Better Leukemia Diagnostics Through AI (BELUGA)

LymphomaMinimal Residual DiseaseLeukemia+2 more
Munich Leukemia Laboratory25,000 enrolled1 locationNCT04466059
Recruiting
Not Applicable

Early Integration of Palliative and Supportive Care in Cellular Therapy

Multiple MyelomaLymphomaLeukemia+3 more
Alberta Health Services, Calgary152 enrolled1 locationNCT05190653
Recruiting

European Rare Blood Disorders Platform (ENROL)

LeukemiaMyelomaAnemia+9 more
Hospital Universitari Vall d'Hebron Research Institute37,090 enrolled1 locationNCT06250595
Recruiting

The Leukemia and Lymphoma Society (LLS) National Research Registry

Blood Cancer
Blood Cancer United1,000 enrolled1 locationNCT04806295
Recruiting
Phase 1

CAR T cell therapy for CD19-positive cancer - phase I clinical trial

B cell blood cancers, including non-Hodgkin's lymphoma and leukaemia.
Metro North Hospital and Health Service31 enrolled1 locationACTRN12621000762853
Recruiting

Australasian Leukaemia and Lymphoma Group National Blood Cancer Registry

Suspected or Known or Diagnosed Blood Cancer
Australasian Leukaemia and Lymphoma Group2,000 enrolled45 locationsACTRN12612000337875